Catechol-0-methyltransferase (EC 2.1.1.6; COMT) catalyses Sadenosylmethionine-dependent methylation of a variety of catechols and plays a role in terminating the activities of the catecholamine neurotransmitters dopamine and noradrenaline. Two isoenzymes, the soluble and membrane-bound forms (S-COMT and MB-COMT) are present in most tissues and although the former is more abundant, their different kinetic parameters suggest that the MB-form may play the dominant role in inactivating the catecholamines [I].
inhibition of S-COMT and MB-COMT by 4,5-dinitrocatechol with respect to catechol. The Ki values were determined for the nitrocatechol derivatives by plotting slopes of the double reciprocal plots against inhibitor concentration and results for both forms of the enzyme are shown in Table 1. . HO *NO2 Figure 1 The structure of a nitrocatechol derivative: The nitrocatechol derivatives used in this work all showed Ki values in the nanomolar range and inhibition by these compounds was competitive. The inhibitors 3,5-dinitrocatechol and Ro 40-7592 displayed tight-binding inhibition and kinetic constants for these, which were significantly lower than for the other compounds, were determined using the method of Dixon [8] . The nitrocatechol derivatives were not more effective in inhibiting the MB-form of the enzyme and in most cases were somewhat less sensitive to inhibition than with S-COMT.
Inhibition studies carried out in this work show the efficacy of nitro-substituted catechols as inhibitors of human cloned S-and MB-COMT in vitro. These compounds were more effective than earlier COMT inhibitors which had Ki values in the micromolar range. Similar observations were made by other workers who noted a difference of two orders of magnitude when comparing their values with those reported for earlier COMT inhibitors [5] . Development of these and other more effective inhibitors could have important clinical implications. Prof. M. Da Prada and Dr. P. Malherbe, Hoffmann-La Roche, Basle, Switzerland are thanked for their kind gift of Escherichiu clones containing plasmids for S-COMT and MB-COMT and also for the nitrocatechol derivatives used in this work. This work was supported by BioResearch, Ireland. 
